Latest News - Allergan

Sunday, July 02, 2017 | Corporate Lawsuits, Allergan

Allergan Settles Whistle-Blower Lawsuit

Allergan settled a whistle-blower lawsuit brought by two Philadelphia-area ophthalmologists who alleged the company provided paid speaking engagements, free business consulting, and other services as …

Read the full story

Thursday, May 11, 2017 | Acquisitions/Mergers, Allergan

Read My Lips, Allergan CEO Tells M&A-Craving Analysts: Don't Expect a Megamerger From Us

Anyone who tuned into Allergan’s Q1 earnings call hoping for signs of big M&A to come likely left disappointed. CEO Brent Saunders, as he has repeatedly over the past year, emphasized Allerg…

Read the full story

Tuesday, April 25, 2017 | FDA Approval/Clearance, Allergan

Allergan Granted Marketing Authorization by the FDA for TrueTear Intranasal Neurostimulating Device

Allergan announced that it has been granted marketing authorization from the FDA for TrueTear Intranasal Tear Neurostimulator, the first and only FDA-cleared device developed to temporarily increase t…

Read the full story

Wednesday, April 19, 2017 | Corporate Lawsuits, Allergan

Allergan, Argentum Settle Patent Dispute Over Restasis

U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan's eye drug, …

Read the full story

Wednesday, March 29, 2017 | Earnings & Financials, Allergan

Allergan's CEO Pay Plummets by 80%

After a 2016 that hit some bumps financially -- and one that didn’t feature the Pfizer-Allergan merger the companies had planned on -- Allergan CEO Brent Saunders’ pay is down. Way, way do…

Read the full story

Wednesday, March 22, 2017 | Product Releases, Allergan

Allergan Announces Availability of Restasis Multidose (Cyclosporine Ophthalmic Emulsion) 0.05%

Allergan announced the availability of Restasis Multidose, the first and only FDA-approved preservative-free, prescription eye drop in the United States to be available in a multidose bottle. Previous…

Read the full story

Thursday, March 16, 2017 | Blindness, Partnerships, Allergan, Prevent Blindness

Prevent Blindness and Allergan Work Together Through 'See America' to Promote Healthy Vision

Prevent Blindness, the nation’s oldest volunteer eye health and safety group, and Allergan, a global leader in eye care for nearly 70 years, have embarked on a joint effort to promote healthy vi…

Read the full story

Tuesday, March 14, 2017 | Product Releases, Allergan

USC Roski Eye Institute Ophthalmologists Are First to Use XEN Gel Stent to Treat Glaucoma Patients in Los Angeles

The University of Southern California (USC) Roski Eye Institute became the first team in Los Angeles county to implant the XEN gel stent in glaucoma patients on March 9, 2017. The XEN gel stent w…

Read the full story

Tuesday, March 14, 2017 | Miscellaneous, Allergan

Award Winning Actor And Hip-Hop Artist Common Joins Allergan's 'See America' Initiative To Further The Fight Against Preventable Blindness

See America, Allergan's initiative to fight against preventable blindness in the United States, unveiled a video featuring award-winning actor and hip-hop artist Common that urges Americans to &qu…

Read the full story

Tuesday, March 14, 2017 | Acquisitions/Mergers, Allergan

Allergan and Editas Medicine Enter Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases

Allergan and Editas Medicine, a genome editing company, announced that Allergan's wholly owned subsidiary, Allergan Pharmaceuticals International Limited, and Editas Medicine have entered into a s…

Read the full story

Thursday, February 23, 2017 | Health Care, Allergan

Allergan CEO Pushes for Trump to Lead Drug Price Discussions

When asked about President Trump’s calls to deal with high US drug costs, Allergan Chief Executive Officer Brent Saunders told Bloomberg News that President Trump should lead negotiations with d…

Read the full story

Tuesday, February 14, 2017 | Glaucoma, Allergan, MIGS

Allergan Announces First Commercial Use of XEN Glaucoma Treatment System in the US

Allergan announced that its XEN Glaucoma Treatment System is now being used by US surgeons to treat refractory glaucoma. The XEN Glaucoma Treatment System, consisting of the XEN45 Gel Stent and the XE…

Read the full story

Monday, February 13, 2017 | Acquisitions/Mergers, Allergan

Allergan to Acquire Zeltiq, Maker of CoolSculpting System, for $2.47 Billion

Allergan has agreed to acquire Zeltiq Aesthetics for $56.50 per share, or $2.475 billion, subject to customary adjustments, the companies announced in a news release. T Allergan said the acquisitio…

Read the full story

Tuesday, February 07, 2017 | Partnerships, Allergan

Allergan Launches 'See America,' an Initiative Furthering the Fight Against Preventable Blindness

Allergan announced a commitment to fight preventable blindness in the United States with a new initiative -- See America. Through See America, Allergan sets out to make vision health a priority for al…

Read the full story

Thursday, December 22, 2016 | Management/Leadership, Allergan

Allergan’s CEO Has Struck an Insane Number of Biotech Deals

Allergan chief Brent Saunders has had a pretty remarkable career trajectory. He headed up Bausch & Lomb until the eye care specialist was snatched up by the (now-infamous) Valeant Pharmaceuticals;…

Read the full story
Load More